References
Key articles
World Health Organization. Clinical management and infection prevention and control for monkeypox: interim rapid response guidance, 10 June 2022. Jun 2022 [internet publication].Full text
Reference articles
1. World Health Organization. Clinical management and infection prevention and control for monkeypox: interim rapid response guidance, 10 June 2022. Jun 2022 [internet publication].Full text
2. Health and Safety Executive, Advisory Committee on Dangerous Pathogens. The approved list of biological agents. July 2021 [internet publication].Full text
3. World Health Organization. WHO recommends new name for monkeypox disease. November 2022 [internet publication].Full text
4. Bunge EM, Hoet B, Chen L, et al. The changing epidemiology of human monkeypox – a potential threat? A systematic review. PLoS Negl Trop Dis. 2022 Feb;16(2):e0010141.Full text Abstract
5. Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis. 2019 Oct;13(10):e0007791.Full text Abstract
6. Nguyen PY, Ajisegiri WS, Costantino V, et al. Reemergence of human monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017-2020. Emerg Infect Dis. 2021 Apr;27(4):1007-14.Full text Abstract
7. World Health Organization. Epidemiology of human monkeypox (mpox) - worldwide, 2018-2021. Jan 2023 [internet publication].Full text
8. Besombes C, Mbrenga F, Schaeffer L, et al. National monkeypox surveillance, Central African Republic, 2001-2021. Emerg Infect Dis. 2022 Nov 3;28(12). Abstract
9. McCollum AM, Shelus V, Hill A, et al. Epidemiology of human mpox: worldwide, 2018-2021. MMWR Morb Mortal Wkly Rep. 2023 Jan 20;72(3):68-72.Full text Abstract
10. Besombes C, Mbrenga F, Malaka C, et al. Investigation of a mpox outbreak in Central African Republic, 2021-2022. One Health. 2023 Jun;16:100523.Full text Abstract
11. World Health Organization. Disease outbreak news: mpox (monkeypox) - Democratic Republic of the Congo. Nov 2023 [internet publication].Full text
12. World Health Organization. 2022-23 mpox (monkeypox) outbreak: global trends. Mar 2024 [internet publication].Full text
13. Centers for Disease Control and Prevention. Notes from the field: emergence of an mpox cluster primarily affecting persons previously vaccinated against mpox - Chicago, Illinois, March 18-June 12, 2023. Jun 2023 [internet publication].Full text
14. León-Figueroa DA, Barboza JJ, Garcia-Vasquez EA, et al. Epidemiological situation of monkeypox transmission by possible sexual contact: a systematic review. Trop Med Infect Dis. 2022 Sep 27;7(10):267.Full text Abstract
15. Kumar R, Singh S, Singh SK. A systematic review of 5110 cases of monkeypox: what has changed between 1970 and 2022? Cureus. 2022 Oct;14(10):e30841.Full text Abstract
16. Liu Q, Fu L, Wang B, et al. Clinical characteristics of human mpox (monkeypox) in 2022: a systematic review and meta-analysis. Pathogens. 2023 Jan 15;12(1):146.Full text Abstract
17. Grothe JH, Cornely OA, Salmanton-García J, et al. Monkeypox in children and adult women in Europe: results from a flash VACCELERATE pilot survey. Enferm Infecc Microbiol Clin. 2022 Sep 19 [Epub ahead of print].Full text Abstract
18. Vallejo-Plaza A, Rodríguez-Cabrera F, Hernando Sebastián V, et al. Mpox (formerly monkeypox) in women: epidemiological features and clinical characteristics of mpox cases in Spain, April to November 2022. Euro Surveill. 2022 Dec;27(48):2200867.Full text Abstract
19. Gaeta F, De Caro F, Franci G, et al. Monkeypox infection 2022: an updated narrative review focusing on the neonatal and pediatric population. Children (Basel). 2022 Nov 26;9(12):1832.Full text Abstract
20. Oakley LP, Hufstetler K, O'Shea J, et al. Mpox cases among cisgender women and pregnant persons: United States, May 11 - November 7, 2022. MMWR Morb Mortal Wkly Rep. 2023 Jan 6;72(1):9-14.Full text Abstract
21. Blackburn D, Roth NM, Gold JAW, et al. Epidemiologic and clinical features of mpox in transgender and gender-diverse adults: United States, May - November 2022. MMWR Morb Mortal Wkly Rep. 2022 Dec 30;71(5152):1605-9.Full text Abstract
22. Wick JM, Pelliccione A, Lee-Rodriguez C, et al. An atypical presentation of mpox transmitted between transgender men through oral sex. Sex Transm Dis. 2023 Oct 1;50(10):685-6.Full text Abstract
23. Kota KK, Hong J, Zelaya C, et al. Racial and ethnic disparities in Mpox cases and vaccination among adult males - United States, May-December 2022. MMWR Morb Mortal Wkly Rep. 2023 Apr 14;72(15):398-403.Full text Abstract
24. Centers for Disease Control and Prevention. Epidemiologic and clinical features of mpox in adults aged >50 years - United States, May 2022-May 2023. Aug 2023 [internet publication].Full text
25. Ogoina D, Dalhat MM, Denue BA, et al. Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study. Lancet Infect Dis. 2023 Aug 22:S1473-3099(23)00427-9.Full text Abstract
26. World Health Organization. Mpox (monkeypox): fact sheet. Apr 2023 [internet publication].Full text
27. Li P, Li J, Ayada I, et al. Clinical features, antiviral treatment and patient outcomes: a systematic review and comparative analysis of the previous and the 2022 mpox outbreaks. J Infect Dis. 2023 Feb 3 [Epub ahead of print].Full text Abstract
28. Centers for Disease Control and Prevention. Emerging infectious diseases: mpox in children and adolescents during multicountry outbreak, 2022-2023. Sep 2023 [internet publication].Full text
29. Hennessee I, Shelus V, McArdle CE, et al. Epidemiologic and clinical features of children and adolescents aged <18 years with monkeypox: United States, May 17 - September 24, 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 4;71(44):1407-11.Full text Abstract
30. Centers for Disease Control and Prevention. Notes from the field: exposures to mpox among cases in children aged ≤12 years - United States, September 25-December 31, 2022. Jun 2023 [internet publication].Full text
31. Centers for Disease Control and Prevention. Clinical considerations for treatment and prophylaxis of mpox infection in people who are immunocompromised. Sep 2023 [internet publication].Full text
32. O'Shea J, Filardo TD, Morris SB, et al. Interim guidance for prevention and treatment of monkeypox in persons with HIV infection: United States, August 2022. MMWR Morb Mortal Wkly Rep. 2022 Aug 12;71(32):1023-8.Full text Abstract
33. Thornhill JP, Palich R, Ghosn J, et al. Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series. Lancet. 2022 Dec 3;400(10367):1953-65.Full text Abstract
34. UK Health Security Agency. Monkeypox case in England. December 2018 [internet publication].Full text
35. UK Health Security Agency. Monkeypox case confirmed in England. December 2019 [internet publication].Full text
36. World Health Organization. Monkeypox: United Kingdom of Great Britain and Northern Ireland. July 2021 [internet publication].Full text
37. World Health Organization. Monkeypox: United Kingdom of Great Britain and Northern Ireland. June 2022 [internet publication].Full text
38. Centers for Disease Control and Prevention. Imported monkeypox case reported in Maryland. November 2021 [internet publication].Full text
39. Centers for Disease Control and Prevention. CDC and Texas confirm monkeypox in U.S. traveler. July 2021 [internet publication].Full text
40. Rao AK, Schulte J, Chen TH, et al. Monkeypox in a traveler returning from Nigeria – Dallas, Texas, July 2021. MMWR Morb Mortal Wkly Rep. 2022 Apr 8;71(14):509-16.Full text Abstract
41. World Health Organization. Disease outbreak news. Monkeypox - Singapore. May 2019 [internet publication].Full text
42. Erez N, Achdout H, Milrot E, et al. Diagnosis of imported monkeypox, Israel, 2018. Emerg Infect Dis. 2019 May;25(5):980-3.Full text Abstract
43. Huhn GD, Bauer AM, Yorita K, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis. 2005 Dec 15;41(12):1742-51.Full text Abstract
44. World Health Organization. Monkeypox: experts give virus variants new names. August 2022 [internet publication].Full text
45. Happi C, Adetifa I, Mbala P, et al. Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus. PLoS Biol. 2022 Aug 23;20(8):e3001769.Full text Abstract
46. Luna N, Ramírez AL, Muñoz M, et al. Phylogenomic analysis of the monkeypox virus (MPXV) 2022 outbreak: emergence of a novel viral lineage? Travel Med Infect Dis. 2022 Jul 13;49:102402. Abstract
47. UK Health Security Agency. Monkeypox outbreak: technical briefings. September 2022 [internet publication].Full text
48. Woolley SD, Lester R, Devine K, et al. Clade IIb A.3 monkeypox virus: an imported lineage during a large global outbreak. Lancet Infect Dis. 2023 Apr;23(4):405.Full text Abstract
49. Jolly B, Scaria V. A distinct phylogenetic cluster of monkeypox genomes suggests an early and cryptic spread of the virus. J Infect. 2023 Jan;86(1):e24-6.Full text Abstract
50. Chmel M, Bartoš O, Kabíčková H, et al. Retrospective analysis revealed an April occurrence of monkeypox in the Czech Republic. Viruses. 2022 Aug 15;14(8):1773.Full text Abstract
51. Centers for Disease Control and Prevention. Clade I–associated mpox cases associated with sexual contact, the Democratic Republic of the Congo. Nov 2023 [internet publication].Full text
52. Sukhdeo S, Mishra S, Walmsley S. Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease. BMC Infect Dis. 2022 Dec 12;22(1):928.Full text Abstract
53. Hatami H, Jamshidi P, Arbabi M, et al. Demographic, epidemiologic, and clinical characteristics of human Monkeypox disease pre- and post-2022 Outbreaks: a systematic review and meta-analysis. Biomedicines. 2023 Mar 20;11(3):957.Full text Abstract
54. Haddad N. The presumed receptivity and susceptibility to monkeypox of European animal species. Infect Dis Now. 2022 Aug;52(5):294-8.Full text Abstract
55. Pinto P, Costa MA, Gonçalves MFM, et al. Mpox person-to-person transmission-where have we got so far? a systematic review. Viruses. 2023 Apr 28;15(5):1074.Full text Abstract
56. UK Health Security Agency. Research and analysis Mpox: transmission, and infectious and incubation periods. Mar 2023 [internet publication].Full text
57. Vanhamel J, Laisnez V, Liesenborghs L, et al. Understanding sexual transmission dynamics and transmission contexts of monkeypox virus: a mixed-methods study of the early outbreak in Belgium (May-June 2022). Sex Transm Infect. 2022 Nov 17 [Epub ahead of print]. Abstract
58. Karan A, Styczynski AR, Huang C, et al. Human monkeypox without viral prodrome or sexual exposure, California, USA, 2022. Emerg Infect Dis. 2022 Aug 16;28(10):2121-3.Full text Abstract
59. Hernandez LE, Jadoo A, Kirsner RS. Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat. Lancet. 2022 Sep 10;400(10355):e8.Full text Abstract
60. Saunders KE, Van Horn AN, Medlin HK, et al. Monkeypox in a young infant: Florida, 2022. MMWR Morb Mortal Wkly Rep. 2022 Sep 23;71(38):1220-1.Full text Abstract
61. Aguilera-Alonso D, Alonso-Cadenas JA, Roguera-Sopena M, et al. Monkeypox virus infections in children in Spain during the first months of the 2022 outbreak. Lancet Child Adolesc Health. 2022 Nov;6(11):e22-3.Full text Abstract
62. Reda A, Abdelaal A, Brakat AM, et al. Monkeypox viral detection in semen specimens of confirmed cases: a systematic review and meta-analysis. J Med Virol. 2022 Oct 22:e28250.Full text Abstract
63. Palich R, Burrel S, Monsel G, et al. Viral loads in clinical samples of men with monkeypox virus infection: a French case series. Lancet Infect Dis. 2023 Jan;23(1):74-80.Full text Abstract
64. Lim CK, McKenzie C, Deerain J, et al. Correlation between monkeypox viral load and infectious virus in clinical specimens. J Clin Virol. 2023 Apr;161:105421.Full text Abstract
65. Rani I, Goyal A, Shamim MA, et al. Prevalence of mpox viral DNA in cutaneous specimens of monkeypox-infected patients: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2023;13:1179885.Full text Abstract
66. World Health Organization. Multi-country monkeypox outbreak: situation update. 27 June 2022 [internet publication].Full text
67. Sah R, Abdelaal A, Reda A, et al. Monkeypox and its possible sexual transmission: where are we now with its evidence? Pathogens. 2022 Aug 17;11(8):924.Full text Abstract
68. Barboza JJ, León-Figueroa DA, Saldaña-Cumpa HM, et al. Virus identification for monkeypox in human seminal fluid samples: a systematic review. Trop Med Infect Dis. 2023 Mar 14;8(3):173.Full text Abstract
69. Peiró-Mestres A, Fuertes I, Camprubí-Ferrer D, et al. Frequent detection of monkeypox virus DNA in saliva, semen, and other clinical samples from 12 patients, Barcelona, Spain, May to June 2022. Euro Surveill. 2022 Jul;27(28):2200503.Full text Abstract
70. Suñer C, Ubals M, Tarín-Vicente EJ, et al. Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain. Lancet Infect Dis. 2022 Dec 12 [Epub ahead of print].Full text Abstract
71. European Centre for Disease Prevention and Control. Monkeypox multi-country outbreak: second update. October 2022 [internet publication].Full text
72. Siedner MJ, Trinidad J, Berto CG, et al. Mpox in young woman with no epidemiologic risk factors, Massachusetts, USA. Emerg Infect Dis. 2023 Jan 25;29(4).Full text Abstract
73. Nörz D, Pfefferle S, Brehm TT, et al. Evidence of surface contamination in hospital rooms occupied by patients infected with monkeypox, Germany, June 2022. Euro Surveill. 2022 Jun;27(26).Full text Abstract
74. Atkinson B, Burton C, Pottage T, et al. Infection-competent monkeypox virus contamination identified in domestic settings following an imported case of monkeypox into the UK. Environ Microbiol. 2022 Oct;24(10):4561-9.Full text Abstract
75. Morgan CN, Whitehill F, Doty JB, et al. Environmental persistence of monkeypox virus on surfaces in household of person with travel-associated infection, Dallas, Texas, USA, 2021. Emerg Infect Dis. 2022 Aug 11;28(10):1982-9.Full text Abstract
76. Muller MP, Mishra S, McGeer A, et al. Environmental testing of surfaces in the room of a patient with mpox. Clin Infect Dis. 2023 Jan 6;76(1):179-81. Abstract
77. Pfeiffer JA, Collingwood A, Rider LE, et al. High-contact object and surface contamination in a household of persons with monkeypox virus infection: Utah, June 2022. MMWR Morb Mortal Wkly Rep. 2022 Aug 26;71(34):1092-4.Full text Abstract
78. Atkinson B, Gould S, Spencer A, et al. Monkeypox virus contamination in an office-based workplace environment. J Hosp Infect. 2022 Dec;130:141-3.Full text Abstract
79. Gould S, Atkinson B, Onianwa O, et al. Air and surface sampling for monkeypox virus in a UK hospital: an observational study. Lancet Microbe. 2022 Dec;3(12):e904-11.Full text Abstract
80. Ramnarayan P, Mitting R, Whittaker E, et al. Neonatal monkeypox virus infection. N Engl J Med. 2022 Oct 27;387(17):1618-20.Full text Abstract
81. Van de Perre P, Molès JP, Rollins N. Is monkeypox virus transmissible by breastfeeding? Pediatr Allergy Immunol. 2022 Oct;33(10):e13861.Full text Abstract
82. Alonso-Cadenas JA, Andina-Martínez D, García-García CJ, et al. Monkeypox disease in a breastfeeding infant. Pediatr Dermatol. 2022 Sep 30 [Epub ahead of print]. Abstract
83. Satapathy P, Mohanty P, Manna S, et al. Potentially asymptomatic infection of monkeypox virus: a systematic review and meta-analysis. Vaccines (Basel). 2022 Dec 6;10(12):2083.Full text Abstract
84. Ward T, Christie R, Paton RS, et al. Transmission dynamics of monkeypox in the United Kingdom: contact tracing study. BMJ. 2022 Nov 2;379:e073153.Full text Abstract
85. Brosius I, Van Dijck C, Coppens J, et al. Presymptomatic viral shedding in high-risk mpox contacts: a prospective cohort study. J Med Virol. 2023 May;95(5):e28769.Full text Abstract
86. Kubo T, Hayakawa K, Akiyama Y, et al. A case of confirmed pre-symptomatic transmission of mpox. J Infect Chemother. 2023 Oct;29(10):1008-9. Abstract
87. Fenner F, Henderson DA, Arita I, et al. Chapter 29: Human monkeypox and other poxvirus infections of man. In: Smallpox and its eradication. Geneva: World Health Organization; 1988.Full text
88. Reda A, El-Qushayri AE, Shah J. Asymptomatic monkeypox infection: a call for greater control of infection and transmission. Lancet Microbe. 2023 Jan;4(1):e15-6.Full text Abstract
89. Ferré VM, Bachelard A, Zaidi M, et al. Detection of monkeypox virus in anorectal swabs from asymptomatic men who have sex with men in a sexually transmitted infection screening program in Paris, France. Ann Intern Med. 2022 Oct;175(10):1491-2.Full text Abstract
90. Moschese D, Pozza G, Mileto D, et al. Isolation of viable monkeypox virus from anal and urethral swabs, Italy, May to July 2022. Euro Surveill. 2022 Sep;27(36).Full text Abstract
91. Cassir N, Cardona F, Tissot-Dupont H, et al. Observational cohort study of evolving epidemiologic, clinical, and virologic features of monkeypox in Southern France. Emerg Infect Dis. 2022 Oct 14;28(12).Full text Abstract
92. Accordini S, Cordioli M, Pomari E, et al. People with asymptomatic or unrecognised infection potentially contribute to monkeypox virus transmission. Lancet Microbe. 2023 Apr;4(4):e209.Full text
93. Rossotti R, Calzavara D, Cernuschi M, et al. Detection of asymptomatic mpox carriers among high-ri men who have sex with men: a prospective analysis. Pathogens. 2023 Jun 3;12(6):798.Full text Abstract
94. Pitt-Kendall R, Foster C, Rayment M, et al. Retrospective testing for mpox virus in routine STI screens from men who have sex with men in England, August-October 2022. Sex Transm Infect. 2023 Aug 3:sextrans-2023-055841. Abstract
95. Hampel B, Farnham A, Lamothe-Molina PJ, et al. Low prevalence of asymptomatic mpox in populations at high risk. Lancet Microbe. 2023 Nov;4(11):e856.Full text
96. Grabmeier-Pfistershammer K, Skorepa C, Breuer M, et al. No evidence of asymptomatic monkeypox infection in a highly sexually active MSM population in Austria. HIV Med. 2023 Aug 31.Full text Abstract
97. Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox virus infection in humans across 16 countries: April–June 2022. N Engl J Med. 2022 Aug 25;387(8):679-91.Full text Abstract
98. Okoli GN, Van Caeseele P, Askin N, et al. Comparative evaluation of the clinical presentation and epidemiology of the 2022 and previous mpox outbreaks: a rapid review and meta-analysis. Infect Dis (Lond). 2023 Jul;55(7):490-508. Abstract
99. Kwok KO, Wei WI, Tang A, et al. Estimation of local transmissibility in the early phase of monkeypox epidemic in 2022. Clin Microbiol Infect. 2022 Dec;28(12):1653.e1-3.Full text Abstract
100. Branda F, Pierini M, Mazzoli S. Monkeypox: early estimation of basic reproduction number R0 in Europe. J Med Virol. 2022 Nov 1:e28270.Full text Abstract
101. Nolen LD, Osadebe L, Katomba J, et al. Introduction of monkeypox into a community and household: risk factors and zoonotic reservoirs in the Democratic Republic of the Congo. Am J Trop Med Hyg. 2015 Aug;93(2):410-5.Full text Abstract
102. Centers for Disease Control and Prevention. Notes from the field: transmission of mpox to nonsexual close contacts - two U.S. jurisdictions, May 1–July 31, 2022. Dec 2023 [internet publication].Full text
103. Kaler J, Hussain A, Flores G, et al. Monkeypox: a comprehensive review of transmission, pathogenesis, and manifestation. Cureus. 2022 Jul;14(7):e26531.Full text Abstract
104. Lum FM, Torres-Ruesta A, Tay MZ, et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol. 2022 Oct;22(10):597-613.Full text Abstract
105. Al-Musa A, Chou J, LaBere B. The resurgence of a neglected orthopoxvirus: Immunologic and clinical aspects of monkeypox virus infections over the past six decades. Clin Immunol. 2022 Oct;243:109108.Full text Abstract
106. World Health Organization. Surveillance, case investigation and contact tracing for mpox (monkeypox): interim guidance, 20 March 2024. Mar 2024 [internet publication].Full text
107. Marshall KE, Barton M, Nichols J, et al. Health care personnel exposures to subsequently laboratory-confirmed monkeypox patients: Colorado, 2022. MMWR Morb Mortal Wkly Rep. 2022 Sep 23;71(38):1216-9.Full text Abstract
108. Marshall KE, Barton M, Nichols J, et al. Health care personnel exposures to subsequently laboratory-confirmed monkeypox patients: Colorado, 2022. Am J Transplant. 2022 Nov;22(11):2699-703.Full text Abstract
109. Safir A, Safir M, Henig O, et al. Nosocomial transmission of MPOX virus to health care workers -an emerging occupational hazard: A case report and review of the literature. Am J Infect Control. 2023 Feb 2 [Epub ahead of print].Full text Abstract
110. Szkiela M, Wiszniewska M, Lipińska-Ojrzanowska A. Monkeypox (Mpox) and occupational exposure. Int J Environ Res Public Health. 2023 Mar 14;20(6):5087.Full text Abstract
111. Ladhani SN, Aiano F, Edwards DS, et al. Very low risk of monkeypox among staff and students after exposure to a confirmed case in educational settings, England, May to July 2022. Euro Surveill. 2022 Oct;27(40).Full text Abstract
112. Tascini C, Geminiani M, Sbrana F, et al. Possible tattoo-transmitted monkeypox viral infection. Intern Emerg Med. 2022 Nov;17(8):2421-2.Full text Abstract
113. Del Río García V, Palacios JG, Morcillo AM, et al. Monkeypox outbreak in a piercing and tattoo establishment in Spain. Lancet Infect Dis. 2022 Sep 29;22(11):1526-8.Full text Abstract
114. Castaño-Fernández JL, Grau-Pérez M. Microblading-transmitted Monkeypox infection: fomites matter. Br J Dermatol. 2023 Mar 11[Epub ahead of print]. Abstract
115. Beaumont AL, Raphaël E, Bertin C, et al. Mpox lesions on a tattoo. Lancet Infect Dis. 2023 Jun;23(6):762.Full text
116. Centers for Disease Control and Prevention. Mpox in animals and pets. Aug 2023 [internet publication].Full text
117. Centers for Disease Control and Prevention. Clinical considerations for mpox in children and adolescents. Sep 2023 [internet publication].Full text
118. Huang YA, Howard-Jones AR, Durrani S, et al. Monkeypox: a clinical update for paediatricians. J Paediatr Child Health. 2022 Sep;58(9):1532-8.Full text Abstract
119. Wendorf KA, Ng R, Stainken C, et al. Household transmission of mpox to children and adolescents, California, 2022. J Infect Dis. 2023 Oct 13:jiad448.Full text Abstract
120. Centers for Disease Control and Prevention. Clinical considerations for mpox in people who are pregnant or breastfeeding. Mar 2023 [internet publication].Full text
121. Dashraath P, Nielsen-Saines K, Rimoin A, et al. Monkeypox and pregnancy: virology, clinical presentation, and obstetric management. Am J Obstet Gynecol. 2022 Dec;227(6):849-61.Full text Abstract
122. D'Antonio F, Pagani G, Buca D, et al. Monkeypox infection in pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2022 Sep 9:100747.Full text Abstract
123. Schwartz DA, Pittman PR. Mpox (monkeypox) in pregnancy: viral clade differences and their associations with varying obstetrical and fetal outcomes. viruses. 2023 Jul 28;15(8):1649.Full text Abstract
124. Attieh RM, Brumble L, Elwasila SM, et al. Disseminated monkeypox infection in a kidney transplant recipient: a case report. Transplant Proc. 2023 Apr;55(3):667-71.Full text Abstract
125. Fuller R, Cederroth T, Patel G, et al. First case of rapidly fatal mpox from secondary (household) transmission in a kidney transplant recipient. Am J Transplant. 2023 Jul 28:S1600-6135(23)00594-4. Abstract
126. Pilkington V, Quinn K, Campbell L, et al. Clinical presentation of Monkeypox in people with and without HIV in the United Kingdom during the 2022 global outbreak. AIDS Res Hum Retroviruses. 2023 May 11[Epub ahead of print]. Abstract
127. Ogoina D, Iroezindu M, James HI, et al. Clinical course and outcome of human monkeypox in Nigeria. Clin Infect Dis. 2020 Nov 5;71(8):e210-4.Full text Abstract
128. Kowalski J, Cielniak I, Garbacz-Łagożna E, et al. Comparison of clinical course of mpox among HIV-negative and HIV-positive patients: a 2022 cohort of hospitalized patients in Central Europe. J Med Virol. 2023 Oct;95(10):e29172. Abstract
129. Curran KG, Eberly K, Russell OO, et al. HIV and sexually transmitted infections among persons with monkeypox: eight US jurisdictions, May 17 - July 22, 2022. MMWR Morb Mortal Wkly Rep. 2022 Sep 9;71(36):1141-7.Full text Abstract
130. Chastain DB, Motoa G, Ortiz-Martínez Y, et al. Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohort. AIDS. 2023 Mar 15;37(4):611-6. Abstract
131. Miller MJ, Cash-Goldwasser S, Marx GE, et al. Severe monkeypox in hospitalized patients: United States, August 10 - October 10, 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 4;71(44):1412-7.Full text Abstract
132. Triana-González S, Román-López C, Mauss S, et al. Risk factors for mortality and clinical presentation of monkeypox. AIDS. 2023 Nov 1;37(13):1979-85. Abstract
133. Mitjà O, Alemany A, Marks M, et al. Mpox in people with advanced HIV infection: a global case series. Lancet. 2023 Mar 18;401(10380):939-49.Full text Abstract
134. Bragazzi NL, Kong JD, Mahroum N, et al. Epidemiological trends and clinical features of the ongoing monkeypox epidemic: a preliminary pooled data analysis and literature review. J Med Virol. 2023 Jan;95(1):e27931. Abstract
135. Thomas A, Hammarlund E, Gao L, et al. Loss of preexisting immunological memory among human immunodeficiency virus-infected women despite immune reconstitution with antiretroviral therapy. J Infect Dis. 2020 Jun 29;222(2):243-51.Full text Abstract
136. Centers for Disease Control and Prevention. Interim clinical guidance for the treatment of mpox. Jul 2023 [internet publication].Full text
137. Xia J, Huang CL, Chu P, et al. Eczema monkeypoxicum: report of monkeypox transmission in a patient with atopic dermatitis. JAAD Case Rep. 2022 Nov;29:95-9.Full text Abstract
138. Napoli E, Frizzell M, Gravell C, et al. Eczema monkeypoxicum in a female patient with atopic dermatitis. Open Forum Infect Dis. 2023 Mar;10(3):ofad072.Full text Abstract
139. Ramoni S, Maronese CA, Morini N, et al. Syphilis and monkeypox co-infection: coincidence, synergy or asymptomatic carriage? Travel Med Infect Dis. 2022 Sep 5;50:102447.Full text Abstract
140. Brooks JT, Marks P, Goldstein RH, et al. Intradermal vaccination for monkeypox: benefits for individual and public health. N Engl J Med. 2022 Sep 29;387(13):1151-3.Full text Abstract
141. Frey SE, Wald A, Edupuganti S, et al. Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects. Vaccine. 2015 Sep 22;33(39):5225-34. Abstract
142. Montalti M, Di Valerio Z, Angelini R, et al. Safety of monkeypox vaccine using active surveillance, two-center observational study in Italy. Vaccines (Basel). 2023 Jun 27;11(7):1163.Full text Abstract
143. US Food and Drug Administration. Monkeypox update: FDA authorizes emergency use of JYNNEOS vaccine to increase vaccine supply. August 2022 [internet publication].Full text
144. Bavarian Nordic. Direct healthcare professional communication: letter to GB/UK healthcare professionals about the differences between Imvanex® brand (licensed in GB/UK) and Jynneos® brand (licensed in US) of live modified vaccinia virus Ankara. September 2022 [internet publication].Full text
145. UK Health Security Agency. Recommendations for the use of pre and post exposure vaccination during a monkeypox incident. August 2022 [internet publication].Full text
146. European Medicines Agency. EMA’s emergency task force advises on intradermal use of Imvanex/Jynneos against monkeypox. August 2022 [internet publication].Full text
147. UK Health Security Agency. Monkeypox: assessment of intradermal dosing of the smallpox vaccine. August 2022 [internet publication].Full text
148. Okumura N, Ishikane M, Ujiie M, et al. "Take" after LC16m8 for mpox. Int J Infect Dis. 2023 Sep;134:290-1.Full text
149. Tomita N, Terada-Hirashima J, Uemura Y, et al. An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox. Hum Vaccin Immunother. 2023 Aug 1;19(2):2242219.Full text Abstract
150. Pittman PR, Hahn M, Lee HS, et al. Phase 3 efficacy trial of modified vaccinia Ankara as a vaccine against smallpox. N Engl J Med. 2019 Nov 14;381(20):1897-908. Abstract
151. Rao AK, Petersen BW, Whitehill F, et al. Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022 Jun 3;71(22):734-42.Full text Abstract
152. Duffy J, Marquez P, Moro P, et al. Safety monitoring of JYNNEOS vaccine during the 2022 mpox outbreak: United States, May 22 - October 21, 2022. MMWR Morb Mortal Wkly Rep. 2022 Dec 9;71(49):1555-9.Full text Abstract
153. Nave L, Margalit I, Tau N, et al. Immunogenicity and safety of modified vaccinia ankara (MVA) vaccine-a systematic review and meta-analysis of randomized controlled trials. Vaccines (Basel). 2023 Aug 24;11(9):1410.Full text Abstract
154. Ryckeley C, Goodwin G, Alvarez-Calderon A. The reemerging condition of vaccinia: a case report and brief review of monkeypox and vaccinia vaccines. Am J Case Rep. 2023 Jun 11;24:e941006.Full text Abstract
155. World Health Organization. Vaccines and immunization for monkeypox: interim guidance, 16 November 2022. November 2022 [internet publication].Full text
156. British HIV Association. BHIVA rapid guidance on monkeypox virus. October 2022 [internet publication].Full text
157. Ladhani SN, Dowell AC, Jones S, et al. Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak response. Lancet Infect Dis. 2023 Sep;23(9):1042-50.Full text Abstract
158. Centers for Disease Control and Prevention. Smallpox: contraindications to vaccination. December 2016 [internet publication].Full text
159. Badell ML, Meaney-Delman D, Tuuli MG, et al. Risks associated with smallpox vaccination in pregnancy: a systematic review and meta-analysis. Obstet Gynecol. 2015 Jun;125(6):1439-51.Full text Abstract
160. Cono J, Casey CG, Bell DM, et al. Smallpox vaccination and adverse reactions: guidance for clinicians. MMWR Recomm Rep. 2003 Feb 21;52(RR-4):1-28.Full text Abstract
161. Halsell JS, Riddle JR, Atwood JE, et al. Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA. 2003 Jun 25;289(24):3283-9.Full text Abstract
162. Dayyab FM, Daiyab HM, Farahat RA. Precautions and recommendations towards possible cardiac manifestations of monkeypox vaccination. Int J Surg. 2022 Sep;105:106898.Full text Abstract
163. UK Health Security Agency. Mpox (monkeypox) outbreak: vaccination strategy. June 2022 [internet publication].Full text
164. Centers for Disease Control and Prevention. Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 US mpox outbreak. Aug 2023 [internet publication].Full text
165. Centers for Disease Control and Prevention. ACIP Recommendations. Oct 2023 [internet publication].Full text
166. Akter F, Hasan TB, Alam F, et al. Effect of prior immunisation with smallpox vaccine for protection against human monkeypox: A systematic review. Rev Med Virol. 2023 Mar 30 [Epub ahead of print].Full text Abstract
167. Criscuolo E, Giuliani B, Ferrarese R, et al. Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox virus Clade II. J Med Virol. 2023 Mar;95(3):e28643.Full text Abstract
168. McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014 Jan;58(2):260-7.Full text Abstract
169. Earl PL, Americo JL, Wyatt LS, et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature. 2004 Mar 11;428(6979):182-5.Full text Abstract
170. Zaeck LM, Lamers MM, Verstrepen BE, et al. Low levels of monkeypox virus neutralizing antibodies after MVA-BN vaccination in healthy individuals. Nat Med. 2022 Oct 18 [Epub ahead of print].Full text Abstract
171. Payne AB, Ray LC, Cole MM, et al. Reduced risk for mpox after receipt of 1 or 2 doses of JYNNEOS vaccine compared with risk among unvaccinated persons: 43 U.S. jurisdictions, July 31 - October 1, 2022. MMWR Morb Mortal Wkly Rep. 2022 Dec 9;71(49):1560-4.Full text Abstract
172. Farrar JL, Lewis NM, Houck K, et al. Demographic and clinical characteristics of mpox in persons who had previously received 1 dose of JYNNEOS vaccine and in unvaccinated persons: 29 U.S. jurisdictions, May 22 - September 3, 2022. MMWR Morb Mortal Wkly Rep. 2022 Dec 30;71(5152):1610-5.Full text Abstract
173. Deputy NP, Deckert J, Chard AN, et al. Vaccine effectiveness of JYNNEOS against mpox disease in the United States. N Engl J Med. 2023 Jun 29;388(26):2434-43. Abstract
174. Turner M, Mandia J, Keltner C, et al. Monkeypox in patient immunized with ACAM2000 smallpox vaccine during 2022 outbreak. Emerg Infect Dis. 2022 Sep 14;28(11):2336-8.Full text Abstract
175. Raccagni AR, Candela C, Mileto D, et al. Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination. J Infect. 2022 Dec 5 [Epub ahead of print].Full text Abstract
176. Berens-Riha N, De Block T, Rutgers J, et al. Severe mpox (formerly monkeypox) disease in five patients after recent vaccination with MVA-BN vaccine, Belgium, July to October 2022. Euro Surveill. 2022 Dec;27(48):2200894.Full text Abstract
177. Hoffmann C, Wolf E, Jessen H, et al. Is there any evidence for milder courses of monkeypox virus infections with childhood smallpox vaccination? Infection. 2022 Sep 20 [Epub ahead of print].Full text Abstract
178. Kandeel M, Morsy MA, Abd El-Lateef HM, et al. Efficacy of the modified vaccinia Ankara virus vaccine and the replication-competent vaccine ACAM2000 in monkeypox prevention. Int Immunopharmacol. 2023 Apr 21;119:110206.Full text Abstract
179. UK Health Security Agency; Public Health Wales; Public Health Agency (Northern Ireland). Principles for control of non-HCID mpox in the UK: 4 nations consensus statement. Jan 2023 [internet publication].Full text
180. UK Health Security Agency. Mpox (monkeypox): case definitions. January 2023 [internet publication].Full text
181. Centers for Disease Control and Prevention. Case definitions for use in the 2022 mpox response. Nov 2023 [internet publication].Full text
182. Mulka L, Cassell J. The changing face of monkeypox. BMJ. 2022 Aug 10;378:o1990.Full text Abstract
183. Centers for Disease Control and Prevention. Health alert network (HAN) health advisory: severe manifestations of monkeypox among people who are immunocompromised due to HIV or other conditions. September 2022 [internet publication].Full text
184. Centers for Disease Control and Prevention. Mpox: clinical recognition. Aug 2023 [internet publication].Full text
185. Philpott D, Hughes CM, Alroy KA, et al. Epidemiologic and clinical characteristics of monkeypox cases: United States, May 17 – July 22, 2022. MMWR Morb Mortal Wkly Rep. 2022 Aug 12;71(32):1018-22.Full text Abstract
186. Patel A, Bilinska J, Tam JCH, et al. Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series. BMJ. 2022 Jul 28;378:e072410.Full text Abstract
187. World Health Organization. Update 79: Monkeypox outbreak update: situation - transmission - countermeasures. August 2022 [internet publication].Full text
188. Centers for Disease Control and Prevention. Updated case-finding guidance: monkeypox outbreak - United States, 2022. Jun 2022 [internet publication].Full text
189. Pfäfflin F, Wendisch D, Scherer R, et al. Monkeypox in-patients with severe anal pain. Infection. 2022 Aug 12 [Epub ahead of print].Full text Abstract
190. Yakubovsky M, Shasha D, Reich S, et al. Monkeypox presenting as proctitis in men who have sex with men. Clin Infect Dis. 2022 Sep 6 [Epub ahead of print].Full text Abstract
191. Rekik S, Pluart DL, Ferré V, et al. Anogenital symptoms and lesions in a series of 20 patients infected with monkeypox virus. Colorectal Dis. 2023 Feb 8 [Epub ahead of print].Full text Abstract
192. Tarín-Vicente EJ, Alemany A, Agud-Dios M, et al. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study. Lancet. 2022 Aug 27;400(10353):661-9.Full text Abstract
193. Shah J, Saak TM, Desai AN, et al. Otolaryngologic manifestations among MPOX patients: a systematic review and meta-analysis. Am J Otolaryngol. 2023 Nov-Dec;44(6):103991. Abstract
194. Boesecke C, Monin MB, van Bremen K, et al. Severe monkeypox-virus infection in undiagnosed advanced HIV infection. Infection. 2022 Dec;50(6):1633-4.Full text Abstract
195. Angelo KM, Smith T, Camprubí-Ferrer D, et al. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study. Lancet Infect Dis. 2022 Oct 7 [Epub ahead of print].Full text Abstract
196. Girometti N, Byrne R, Bracchi M, et al. Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis. Lancet Infect Dis. 2022 Sep;22(9):1321-8.Full text Abstract
197. European Centre for Disease Prevention and Control. Monkeypox cases reported in UK and Portugal. May 2022 [internet publication].Full text
198. Patrocinio-Jesus R, Peruzzu F. Monkeypox genital lesions. N Engl J Med. 2022 Jul 7;387(1):66.Full text Abstract
199. Orviz E, Negredo A, Ayerdi O, et al. Monkeypox outbreak in Madrid (Spain): clinical and virological aspects. J Infect. 2022 Oct;85(4):412-7.Full text Abstract
200. Català A, Clavo Escribano P, Riera J, et al. Monkeypox outbreak in Spain: clinical and epidemiological findings in a prospective cross-sectional study of 185 cases. Br J Dermatol. 2022 Nov;187(5):765-72.Full text Abstract
201. Quattri E, Avallone G, Maronese CA, et al. Unilesional monkeypox: a report of two cases from Italy. Travel Med Infect Dis. 2022 Aug 10;49:102424.Full text Abstract
202. Ciccarese G, Brucci G, Di Biagio A, et al. Two cases of monkeypox virus infection without detectable cutaneous/mucosal lesions. Travel Med Infect Dis. 2023 Jul-Aug;54:102605.Full text
203. Ardila CM, Arrubla-Escobar DE, Vivares-Builes AM. Oral lesions in patients with human monkeypox: a systematic scoping review. J Oral Pathol Med. 2022 Oct 20 [Epub ahead of print]. Abstract
204. Mishra S, Khan R, Krizova A, et al. Esophageal monkeypox lesion. Clin Gastroenterol Hepatol. 2022 Sep 26 [Epub ahead of print].Full text Abstract
205. Williams G, Watters C, Watson N. Auricular manifestation of mpox (monkeypox). BMJ Case Rep. 2023 Jan 19;16(1):e252931.Full text Abstract
206. Portela-Dias J, Sereno S, Falcão-Reis I, et al. Female monkeypox infection with localized genital lesions. Am J Obstet Gynecol. 2022 Aug 25 [Epub ahead of print].Full text Abstract
207. Vallée A, Chatelain A, Carbonnel M, et al. Monkeypox virus infection in 18-year-old woman after sexual intercourse, France, September 2022. Emerg Infect Dis. 2022 Nov 10;29(1).Full text Abstract
208. Zayat N, Huang S, Wafai J, et al. Monkeypox virus infection in 22-year-old woman after sexual intercourse, New York, USA. Emerg Infect Dis. 2022 Nov 10;29(1).Full text Abstract
209. Ramírez M, Delso V, Sánchez MJ, et al. Mpox (monkeypox) presenting as cervical and vulvar disease. Obstet Gynecol. 2023 Jan 10 [Epub ahead of print].Full text Abstract
210. Prasad S, Casas CG, Strahan AG, et al. A dermatologic assessment of 101 mpox (monkeypox) cases from 13 countries during the 2022 outbreak: skin lesion morphology, clinical course, and scarring. J Am Acad Dermatol. 2023 Jan 11 [Epub ahead of print].Full text Abstract
211. Gomez-Garberi M, Sarrio-Sanz P, Martinez-Cayuelas L, et al. Genitourinary lesions due to monkeypox. Eur Urol. 2022 Dec;82(6):625-30.Full text Abstract
212. Simon-Gozalbo A, Gamo-Guerrero M, Alonso-Garcia S, et al. Haemorrhagic monkeypox infection in an immunosuppressed patient with human immunodeficiency virus: beyond the pustules. Clin Microbiol Infect. 2023 Jan;29(1):122-4.Full text Abstract
213. NHS England. Management of laboratory confirmed mpox infections. February 2023 [internet publication].Full text
214. World Health Organization. Diagnostic testing for the monkeypox virus (MPXV): interim guidance. Nov 2023 [internet publication].Full text
215. UK Health Security Agency. Mpox (monkeypox): diagnostic testing. Jan 2024 [internet publication].Full text
216. Centers for Disease Control and Prevention. Guidelines for collecting and handling specimens for mpox testing. September 2022 [internet publication].Full text
217. Altindis M, Puca E, Shapo L. Diagnosis of monkeypox virus: an overview. Travel Med Infect Dis. 2022 Sep 13;50:102459.Full text Abstract
218. Gul I, Liu C, Yuan X, et al. Current and perspective sensing methods for monkeypox virus. Bioengineering (Basel). 2022 Oct 18;9(10):571.Full text Abstract
219. Minhaj FS, Petras JK, Brown JA, et al. Orthopoxvirus testing challenges for persons in populations at low risk or without known epidemiologic link to monkeypox: United States, 2022. MMWR Morb Mortal Wkly Rep. 2022 Sep 9;71(36):1155-8.Full text Abstract
220. Centers for Disease Control and Prevention. Update for clinicians on testing and treatment for monkeypox. July 2022 [internet publication].Full text
221. Paran N, Yahalom-Ronen Y, Shifman O, et al. Monkeypox DNA levels correlate with virus infectivity in clinical samples, Israel, 2022. Euro Surveill. 2022 Sep;27(35).Full text Abstract
222. Martins-Filho PR, Tanajura DM, Alves Dos Santos C. Polymerase chain reaction positivity and cycle threshold values in biological samples from patients with monkeypox: a meta-analysis. Travel Med Infect Dis. 2022 Sep 7;50:102448.Full text Abstract
223. Hasso M, Perusini S, Eshaghi A, et al. Monkeypox virus detection in different clinical specimen types. Emerg Infect Dis. 2022 Oct 12;28(12).Full text Abstract
224. Nörz D, Brehm TT, Tang HT, et al. Clinical characteristics and comparison of longitudinal qPCR results from different specimen types in a cohort of ambulatory and hospitalized patients infected with monkeypox virus. J Clin Virol. 2022 Aug 11;155:105254.Full text Abstract
225. US Food and Drug Administration. For monkeypox testing, use lesion swab samples to avoid false results: FDA safety communication. July 2022 [internet publication].Full text
226. Veintimilla C, Catalán P, Alonso R, et al. The relevance of multiple clinical specimens in the diagnosis of monkeypox virus, Spain, June 2022. Euro Surveill. 2022 Aug;27(33).Full text Abstract
227. Allan-Blitz LT, Carragher K, Sukhija-Cohen A, et al. Laboratory validation and clinical performance of a saliva-based test for monkeypox virus. J Med Virol. 2023 Jan;95(1):e28191.Full text Abstract
228. Messina MD, Wolf EL, Kanmaniraja D, et al. Imaging features of anorectal proctitis in monkeypox infection. Clin Imaging. 2022 Dec;92:109-11.Full text Abstract
229. Titanji BK, Tegomoh B, Nematollahi S, et al. Monkeypox: a contemporary review for healthcare professionals. Open Forum Infect Dis. 2022 Jul;9(7):ofac310.Full text Abstract
230. El Eid R, Allaw F, Haddad SF, et al. Human monkeypox: a review of the literature. PLoS Pathog. 2022 Sep;18(9):e1010768.Full text Abstract
231. Sui Y, Xu Q, Liu M, et al. CRISPR-Cas12a-based detection of monkeypox virus. J Infect. 2022 Dec;85(6):702-69.Full text Abstract
232. Feng J, Xue G, Cui X, et al. Development of a loop-mediated isothermal amplification method for rapid and visual detection of monkeypox virus. Microbiol Spectr. 2022 Sep 26:e0271422.Full text Abstract
233. Thieme AH, Zheng Y, Machiraju G, et al. A deep-learning algorithm to classify skin lesions from mpox virus infection. Nat Med. 2023 Mar;29(3):738-47.Full text Abstract
234. Hussain A, Kaler J, Lau G, et al. Clinical conundrums: differentiating monkeypox from similarly presenting infections. Cureus. 2022 Oct;14(10):e29929.Full text Abstract
235. El-Qushayri AE, Reda A, Shah J. COVID-19 and monkeypox co-infection: a rapid systematic review. Front Immunol. 2022 Dec 14;13:1094346.Full text Abstract
236. Kaiser RM, Cash-Goldwasser S, Lehnertz N, et al. Pharyngeal co-infections with monkeypox virus and group A streptococcus, United States, 2022. Emerg Infect Dis. 2023 Sep;29(9):1855-8.Full text Abstract
237. Oprea C, Ionuț Popa, Ianache I, et al. Monkeypox, severe hepatitis A, and syphilis in an HIV returning traveler from Spain to Romania. Travel Med Infect Dis. 2022 Sep 8:102455.Full text Abstract
238. Ola D, Dane B, Shanbhogue K, et al. Rectal and perirectal CT findings in patients with monkeypox virus infection. Abdom Radiol (NY). 2023 May 6 [Epub ahead of print].Full text Abstract
239. Martins-Filho PR, Dorea FCM, Sena LOC, et al. First reports of monkeypox and varicella-zoster virus coinfection in the global human monkeypox outbreak in 2022. Travel Med Infect Dis. 2023 Jan-Feb;51:102510.Full text Abstract
240. Hughes CM, Liu L, Davidson WB, et al. A tale of two viruses: coinfections of monkeypox and varicella zoster virus in the Democratic Republic of Congo. Am J Trop Med Hyg. 2020 Dec 7;104(2):604-11.Full text Abstract
241. Liu Y, Li X, Yan H, et al. A case of orf virus infection in the human: other zoonotic poxvirus infection events should not be ignored during the mpox epidemic. Travel Med Infect Dis. 2023 May-Jun;53:102588.Full text
242. European Centre for Disease Prevention and Control. Monkeypox (MPX) reporting protocol 2022, version 3.2. September 2022 [internet publication].Full text
243. UK Health Security Agency. Monkeypox: contact tracing. January 2023 [internet publication].Full text
244. Centers for Disease Control and Prevention. Infection prevention and control of mpox in healthcare settings. Oct 2022 [internet publication].Full text
245. Centers for Disease Control and Prevention. Mpox: information for healthcare professionals. Sep 2022 [internet publication].Full text
246. Australian Government Department of Health. Mpox (monkeypox). Sep 2022 [internet publication].Full text
247. UK Health Security Agency. Mpox (monkeypox): background information. Jul 2022 [internet publication].Full text
248. Webb E, Rigby I, Michelen M, et al. Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review. BMJ Glob Health. 2022 Aug;7(8):e009838.Full text Abstract
249. UK Health Security Agency. HCID status of mpox (monkeypox). January 2023 [internet publication].Full text
250. Centers for Disease Control and Prevention. Clinical considerations for pain management of mpox. Mar 2023 [internet publication].Full text
251. Hans GH, Wildemeersch D, Meeus I. Integrated analgesic care in the current human monkeypox outbreak: perspectives on an integrated and holistic approach combining old allies with innovative technologies. Medicina (Kaunas). 2022 Oct 15;58(10):1454.Full text Abstract
252. Lucar J, Roberts A, Saardi KM, et al. Monkeypox virus-associated severe proctitis treated with oral tecovirimat: a report of two cases. Ann Intern Med. 2022 Aug 18 [Epub ahead of print].Full text Abstract
253. Hallo-Carrasco A, Hunt CL, Prusinski CC, et al. Pain associated with monkeypox virus: a rapid review. Cureus. 2023 Feb;15(2):e34697.Full text Abstract
254. British Association for Sexual Health and HIV. Monkeypox management recommendations (proctitis). June 2022 [internet publication].Full text
255. Maredia H, Sartori-Valinotti JC, Ranganath N, et al. Supportive care management recommendations for mucocutaneous manifestations of monkeypox infection. Mayo Clin Proc. 2023 Apr 29 [Epub ahead of print].Full text Abstract
256. de Sousa D, Frade J, Patrocínio J, et al. Monkeypox infection and bacterial cellulitis: a complication to look for. Int J Infect Dis. 2022 Oct;123:180-2.Full text Abstract
257. American Academy of Dermatology Association. Mpox: treating severe lesions [internet publication].Full text
258. Reda A, Hemmeda L, Brakat AM, et al. The clinical manifestations and severity of the 2022 monkeypox outbreak among 4080 patients. Travel Med Infect Dis. 2022 Sep 15 [Epub ahead of print].Full text Abstract
259. Fink DL, Callaby H, Luintel A, et al. Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study. Lancet Infect Dis. 2022 Dec 22 [Epub ahead of print].Full text Abstract
260. DeWitt ME, Polk C, Williamson J, et al. Global monkeypox case hospitalisation rates: a rapid systematic review and meta-analysis. EClinicalMedicine. 2022 Dec;54:101710.Full text Abstract
261. de Oliveira-Júnior JM, Tenório MDL, Dos Santos Caduda S, et al. Reasons for hospitalization of patients with monkeypox: a quantitative evidence synthesis. Infection. 2022 Oct 18 [Epub ahead of print].Full text Abstract
262. Siegrist EA, Sassine J. Antivirals with activity against monkeypox: a clinically oriented review. Clin Infect Dis. 2022 Jul 29 [Epub ahead of print].Full text Abstract
263. Shamim MA, Padhi BK, Satapathy P, et al. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review. Int J Infect Dis. 2023 Feb;127:150-61.Full text Abstract
264. Centers for Disease Control and Prevention. Interim clinical treatment considerations for severe manifestations of Mpox — United States, February 2023. Mar 2023 [internet publication].Full text
265. Medicines and Healthcare products Regulatory Agency. Tecovirimat as a treatment for patients hospitalised due to monkeypox viral infection. September 2022 [internet publication].Full text
266. Smith TG, Gigante CM, Wynn NT, et al. Tecovirimat resistance in mpox patients, United States, 2022-2023. Emerg Infect Dis. 2023 Oct 19;29(12).Full text Abstract
267. Mertes H, Rezende AM, Brosius I, et al. Tecovirimat resistance in an immunocompromised patient with mpox and prolonged viral shedding. Ann Intern Med. 2023 Aug;176(8):1141-3.Full text
268. Centers for Disease Control and Prevention. Update on managing monkeypox in patients receiving therapeutics. November 2022 [internet publication].Full text
269. Seifu L, Garcia E, McPherson TD, et al. Notes from the field: posttreatment lesions after tecovirimat treatment for Mpox - New York City, August-September 2022. MMWR Morb Mortal Wkly Rep. 2023 Apr 28;72(17):471-2.Full text Abstract
270. Fox T, Gould S, Princy N, et al. Therapeutics for treating mpox in humans. Cochrane Database Syst Rev. 2023 Mar 14;(3):CD015769.Full text Abstract
271. ClinicalTrials.gov. A trial to assess the safety, tolerability, and pharmacokinetics of the anti-orthopoxvirus compound tecovirimat (SIGA246-008). November 2017 [internet publication].Full text
272. Grosenbach DW, Honeychurch K, Rose EA, et al. Oral tecovirimat for the treatment of smallpox. N Engl J Med. 2018 Jul 5;379(1):44-53.Full text Abstract
273. Adler H, Gould S, Hine P, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022 Aug;22(8):1153-62.Full text Abstract
274. Matias WR, Koshy JM, Nagami EH, et al. Tecovirimat for the treatment of human monkeypox: an initial series from Massachusetts, United States. Open Forum Infect Dis. 2022 Aug;9(8):ofac377.Full text Abstract
275. Desai AN, Thompson GR 3rd, Neumeister SM, et al. Compassionate use of tecovirimat for the treatment of monkeypox infection. JAMA. 2022 Oct 4;328(13):1348-150.Full text Abstract
276. O'Laughlin K, Tobolowsky FA, Elmor R, et al. Clinical use of tecovirimat (Tpoxx) for treatment of monkeypox under an investigational new drug protocol: United States, May - August 2022. MMWR Morb Mortal Wkly Rep. 2022 Sep 16;71(37):1190-5.Full text Abstract
277. Viguier C, de Kermel T, Boumaza X, et al. A severe monkeypox infection in a patient with an advanced HIV infection treated with tecovirimat: clinical and virological outcome. Int J Infect Dis. 2022 Oct 29;125:135-7.Full text Abstract
278. Mbrenga F, Nakouné E, Malaka C, et al. Tecovirimat for monkeypox in Central African Republic under expanded access. N Engl J Med. 2022 Dec 15;387(24):2294-5.Full text Abstract
279. Wu EL, Osborn RL, Bertram CM, et al. Tecovirimat use in ambulatory and hospitalized patients with monkeypox virus infection. Sex Transm Dis. 2022 Dec 2 [Epub ahead of print]. Abstract
280. Hermanussen L, Brehm TT, Wolf T, et al. Tecovirimat for the treatment of severe mpox in Germany. Infection. 2023 Oct;51(5):1563-8.Full text Abstract
281. Rojek A, Dunning J, Olliaro P. Monkeypox: how will we know if the treatments work? Lancet Infect Dis. 2022 Sep;22(9):1269-70.Full text Abstract
282. National Institute for Health and Care Research. Efficacy of tecovirimat for the treatment of non-hospitalised patients with confirmed monkeypox: research brief. May 2022 [internet publication].Full text
283. University of Oxford. PLATINUM: placebo-controlled randomised trial of tecovirimat in non-hospitalised monkeypox patients. 2022 [internet publication].Full text
284. National Institutes of Health. STOMP: study of tecovirimat for human monkeypox virus. 2022 [internet publication].Full text
285. McLean J, Stoeckle K, Huang S, et al. Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak : A Retrospective Cohort Study. Ann Intern Med. 2023 May 2 [Epub ahead of print].Full text Abstract
286. Aldred B, Lyles RH, Scott JY, et al. Early tecovirimat treatment for mpox disease among people with HIV. JAMA Intern Med. 2024 Mar 1;184(3):275-9. Abstract
287. Stittelaar KJ, Neyts J, Naesens L, et al. Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Nature. 2006 Feb 9;439(7077):745-8.Full text Abstract
288. Huggins J, Goff A, Hensley L, et al. Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246. Antimicrob Agents Chemother. 2009 Jun;53(6):2620-5.Full text Abstract
289. Fabrizio C, Bruno G, Cristiano L, et al. Cidofovir for treating complicated monkeypox in a man with acquired immune deficiency syndrome. Infection. 2022 Nov 10 [Epub ahead of print].Full text Abstract
290. Raccagni AR, Candela C, Bruzzesi E, et al. Real-life use of cidofovir for the treatment of severe monkeypox cases. J Med Virol. 2022 Oct 13 [Epub ahead of print].Full text Abstract
291. Mondi A, Gagliardini R, Mazzotta V, et al. Clinical experience with use of oral tecovirimat or intravenous cidofovir for the treatment of monkeypox in an Italian reference hospital. J Infect. 2022 Nov 5 [Epub ahead of print].Full text Abstract
292. Labate L, Brucci G, Ciccarese G, et al. Nasal monkeypox virus infection successfully treated with cidofovir in a patient newly diagnosed with HIV. Int J STD AIDS. 2022 Dec 15 [Epub ahead of print]. Abstract
293. Stafford A, Rimmer S, Gilchrist M, et al. Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection. Lancet Infect Dis. 2023 Feb 8 [Epub ahead of print].Full text Abstract
294. UK Health Security Agency. De-isolation and discharge of mpox-infected patients: interim guidance. September 2022 [internet publication].Full text
295. Sampson MM, Magee G, Schrader EA, et al. Mpox (Monkeypox) infection during pregnancy. Obstet Gynecol. 2023 May 1;141(5):1007-10. Abstract
296. Dashraath P, Nielsen-Saines K, Mattar C, et al. Guidelines for pregnant individuals with monkeypox virus exposure. Lancet. 2022 Jul 2;400(10345):21-2.Full text Abstract
297. Khalil A, Samara A, O'Brien P, et al. Monkeypox and pregnancy: what do obstetricians need to know? Ultrasound Obstet Gynecol. 2022 Jul;60(1):22-7.Full text Abstract
298. Raccagni AR, Mileto D, Galli L, et al. HIV viral load monitoring during monkeypox virus infection among PLWH. AIDS. 2023 Jan 9 [Epub ahead of print]. Abstract
299. National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Panel on guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: mpox. Jul 2023 [internet publication].Full text
300. Centers for Disease Control and Prevention. Guidance for tecovirimat use: expanded access investigational new drug protocol during 2022 US mpox outbreak. Jun 2023 [internet publication].Full text
301. Mazurkov OY, Kabanov AS, Shishkina LN, et al. New effective chemically synthesized anti-smallpox compound NIOCH-14. J Gen Virol. 2016 May;97(5):1229-39.Full text Abstract
302. Sobral-Costas TG, Escudero-Tornero R, Servera-Negre G, et al. Human monkeypox outbreak: epidemiological data and therapeutic potential of topical cidofovir in a prospective cohort study. J Am Acad Dermatol. 2022 Nov 28 [Epub ahead of print].Full text Abstract
303. Rubio-Muniz CA, Montero-Menárguez J, López-Valle A, et al. Monkeypox: is topical cidofovir a good idea? Clin Exp Dermatol. 2023 Feb 2;48(2):132-4. Abstract
304. Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel. Section 5: travel-associated infections & diseases - smallpox and other orthopoxvirus-associated infections. May 2023 [internet publication].Full text
305. Infectious Diseases Society of America; HIV Medicine Association. Mpox in the US: resources for HIV clinicians. December 2022 [internet publication].Full text
306. World Health Organization. Mpox (monkeypox) outbreak toolbox. Nov 2023 [internet publication].Full text
307. UK Health Security Agency. Mpox (monkeypox): guidance. Apr 2023 [internet publication].Full text
308. UK Health Security Agency. Mpox (monkeypox): people who are isolating at home. September 2022 [internet publication].Full text
309. Berens-Riha N, Bracke S, Rutgers J, et al. Persistent morbidity in Clade IIb mpox patients: interim results of a long-term follow-up study, Belgium, June to November 2022. Euro Surveill. 2023 Feb;28(7):2300072.Full text Abstract
310. Riser AP, Hanley A, Cima M, et al. Epidemiologic and clinical features of mpox-associated deaths - United States, May 10, 2022-March 7, 2023. MMWR Morb Mortal Wkly Rep. 2023 Apr 14;72(15):404-10.Full text Abstract
311. Menezes YR, Miranda AB. Severe disseminated clinical presentation of monkeypox virus infection in an immunosuppressed patient: first death report in Brazil. Rev Soc Bras Med Trop. 2022 Aug 29;55:e0392.Full text Abstract
312. Sah R, Mohanty A, Abdelaal A, et al. First Monkeypox deaths outside Africa: no room for complacency. Ther Adv Infect Dis. 2022 Jan-Dec;9:20499361221124027.Full text Abstract
313. Filippov E, Duhan S, Lehman L, et al. Treatment failure in patient with severe mpox and untreated HIV, Maryland, USA. Emerg Infect Dis. 2023 May 12;29(6) [Epub ahead of print]. Abstract
314. Golden J, Harryman L, Crofts M, et al. Case of apparent mpox reinfection. Sex Transm Infect. 2023 Jan 27 [Epub ahead of print].Full text Abstract
315. Musumeci S, Najjar I, Boffi El Amari E, et al. A case of mpox reinfection. Clin Infect Dis. 2023 Mar 11 [Epub ahead of print].Full text Abstract
316. Zeggagh J, Ferraris O, Salmona M, et al. Second clinical episode of hMPX virus in a man having sex with men. Lancet. 2023 May 13;401(10388):1610. Abstract
317. Álvarez-López P, Borras-Bermejo B, López Pérez L, et al. Suspected case of monkeypox reinfection versus reactivation in a immunocompetent patient, Barcelona, 2022. Int J STD AIDS. 2023 Apr 26 [Epub ahead of print]. Abstract
318. Rocha SQ, Fonsi M, Tancredi MV, et al. Mpox in a couple living with HIV: relapse or reinfection? AIDS Res Hum Retroviruses. 2023 May 4 [Epub ahead of print]. Abstract
319. Hazra A, Zucker J, Bell E, et al. Mpox in people with past infection or a complete vaccination course: a global case series. Lancet Infect Dis. 2023 Sep 4:S1473-3099(23)00492-9.Full text Abstract
320. Di Bari S, Mondi A, Pinnetti C, et al. A case of severe mpox complicated with streptococcus pyogenes sepsis in a patient with HIV infection. Pathogens. 2023 Aug 23;12(9):1073.Full text Abstract
321. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143.Full text Abstract
322. Mailhe M, Beaumont AL, Thy M, et al. Clinical characteristics of ambulatory and hospitalised patients with monkeypox virus infection: an observational cohort study. Clin Microbiol Infect. 2022 Aug 23 [Epub ahead of print].Full text Abstract
323. Frade JV, Sousa I, Marques T, et al. Acute paronychia: an atypical presentation of monkeypox infection. Enferm Infecc Microbiol Clin. 2022 Oct 28 [Epub ahead of print].Full text Abstract
324. Smith K, Tyson K, Hossain R, et al. Progressively confluent monkeypox lesions with necrosis. Oxf Med Case Reports. 2023 Jan 18 [Epub ahead of print].Full text Abstract
325. Frade JV, Sousa I, Marques T, et al. Acute paronychia: an atypical presentation of Monkeypox infection. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jan 27 [Epub ahead of print].Full text Abstract
326. Li H, Maddy A, Patel BM, et al. Hypertrophic verrucous mpox as a sign of disease progression. JAAD Case Rep. 2023 Aug;38:38-40.Full text
327. Farley R, Sarver J, Milliner B, et al. Genital infection from monkeypox virus requiring surgical debridement and scrotoplasty in an immunocompromised patient. Urol Case Rep. 2023 Jul;49:102438. Abstract
328. Gaertner F, Preissner S, Petri WA Jr, et al. Comparison of the risk of hospital admission, need for ventilation, sepsis, pneumonitis and death among the recent monkeypox outbreak and historical outbreaks. BMC Infect Dis. 2023 Sep 18;23(1):610.Full text Abstract
329. Dumont M, Guilhou T, Gerin M, et al. Myocarditis in monkeypox-infected patients: a case series. Clin Microbiol Infect. 2022 Dec 9 [Epub ahead of print].Full text Abstract
330. Jaiswal V, Sultana Q, Lahori S, et al. Monkeypox-induced myocarditis: a systematic review. Curr Probl Cardiol. 2023 Jan 27 [Epub ahead of print].Full text Abstract
331. Maqbool KU, Arsh H, Kumar D, et al. Cardiovascular manifestations of human monkeypox virus: an updated review. Curr Probl Cardiol. 2023 Jun 9;48(10):101869.Full text Abstract
332. Rayati Damavandi A, Semnani F, Hassanpour K. A review of monkeypox ocular manifestations and complications: insights for the 2022 outbreak. Ophthalmol Ther. 2023 Feb;12(1):55-69.Full text Abstract
333. Carvalho EM, Medeiros M, Veloso VG, et al. Monkeypox infection causing conjunctival vesicles and anterior uveitis. Ocul Immunol Inflamm. 2023 Feb 17 [Epub ahead of print]. Abstract
334. Mukit FA, Louie EM, Cape HT, et al. A suspected case of a neonatal monkeypox infection with ocular involvement. Cureus. 2023 May;15(5):e38819.Full text Abstract
335. Nguyen MT, Mentreddy A, Schallhorn J, et al. Isolated ocular Mpox without skin lesions, United States. Emerg Infect Dis. 2023 May 2;29(6):10. Abstract
336. Centers for Disease Control and Prevention. Interim clinical considerations for management of ocular mpox virus infection. Mar 2023 [internet publication].Full text
337. Finamor LPS, de Freitas D, Andrade G, et al. Tecovirimat treatment for monkeypox virus keratouveitis. JAMA Ophthalmol. 2022 Dec 22 [Epub ahead of print].Full text Abstract
338. Perzia B, Theotoka D, Li K, et al. Treatment of ocular-involving monkeypox virus with topical trifluridine and oral tecovirimat in the 2022 monkeypox virus outbreak. Am J Ophthalmol Case Rep. 2023 Mar;29:101779.Full text Abstract
339. Davido B, D'Anglejan E, Baudoin R, et al. Monkeypox outbreak 2022: an unusual case of peritonsillar abscess in a person previously vaccinated against smallpox. J Travel Med. 2022 Sep 17;29(6):taac082. Abstract
340. Mathieson T, Dulguerov N, Mermod M. Monkeypox mucosal lesions. IDCases. 2022 Aug 17;29:e01600.Full text Abstract
341. Meng X. Clinical manifestations of the pharynx in human monkeypox. Travel Med Infect Dis. 2022 Sep 26;50:102465.Full text Abstract
342. Mahtani AU, Engome YM, Haider M, et al. Paraphimosis as a complication of monkeypox infection. J Surg Case Rep. 2022 Nov;2022(11):rjac533.Full text Abstract
343. Milano E, Belati A, De Santis L, et al. First case of paraphimosis as a severe complication of monkeypox. Vaccines (Basel). 2022 Dec 28;11(1):63.Full text Abstract
344. Poole M, Mehrmal S, Kremer M, et al. An atypical presentation of monkeypox associated with scrotal and penile shaft edema. JAAD Case Rep. 2023 Jan 20 [Epub ahead of print].Full text Abstract
345. Kapmaz M, Uymaz DS, Özcan G, et al. A complicated case of monkeypox and viral shedding characteristics. J Infect. 2022 Oct 20 [Epub ahead of print].Full text Abstract
346. Brown L, Delaney C, Hainsworth A. Monkeypox-associated proctitis and rectal wall perforation. BMJ Case Rep. 2023 Jan 17;16(1):e252168.Full text Abstract
347. Saleh H, Ho BT, Call JT, et al. Severe Mpox proctitis complicated by bowel obstruction. ACG Case Rep J. 2023 May;10(5):e01048.Full text Abstract
348. Taj S, Austin C, Hussain A, et al. Severe gastrointestinal hemorrhage due to monkeypox virus-associated proctocolitis. Case Rep Gastrointest Med. 2023;2023:9981631.Full text Abstract
349. Hackett N, Narayan P, Huf S. Mpox (monkeypox) causing penile lesions and acute urinary retention. BMJ Case Rep. 2022 Dec 14;15(12):e252696.Full text Abstract
350. Fonti M, Mader T, Burmester-Kiang J, et al. Monkeypox associated acute arthritis. Lancet Rheumatol. 2022 Sep 12 [Epub ahead of print].Full text Abstract
351. Lombès A, Zmerli M, Nerozzi-Banfi E, et al. Arthritis due to monkeypox virus: a case report. Joint Bone Spine. 2022 Nov 18;90(2):105492.Full text Abstract
352. Badenoch JB, Conti I, Rengasamy ER, et al. Neurological and psychiatric presentations associated with human monkeypox virus infection: a systematic review and meta-analysis. EClinicalMedicine. 2022 Oct;52:101644.Full text Abstract
353. Billioux BJ, Mbaya OT, Sejvar J, et al. Neurologic complications of smallpox and monkeypox: a review. JAMA Neurol. 2022 Sep 20 [Epub ahead of print].Full text Abstract
354. Money KM, Barnett TA, Rapaka S, et al. Monkeypox-associated central nervous system disease: a case series and review. Ann Neurol. 2023 Jan 5 [Epub ahead of print].Full text Abstract
355. Pastula DM, Copeland MJ, Hannan MC, et al. Two cases of monkeypox-associated encephalomyelitis: Colorado and the District of Columbia, July - August 2022. MMWR Morb Mortal Wkly Rep. 2022 Sep 23;71(38):1212-5.Full text Abstract
356. Cole J, Choudry S, Kular S, et al. Monkeypox encephalitis with transverse myelitis in a female patient. Lancet Infect Dis. 2022 Dec 2 [Epub ahead of print].Full text Abstract
357. Khan SA, Parajuli SB, Rauniyar VK. Neurological manifestations of an emerging zoonosis-human monkeypox virus: a systematic review. Medicine (Baltimore). 2023 Sep 1;102(35):e34664.Full text Abstract
358. Abdul Hamid T, Mustafa N, Zulfiquar Parkar A, et al. Manifestation of guillain-barre syndrome in a case of monkeypox virus infection: a rare case report. Case Rep Infect Dis. 2023;2023:2426659.Full text Abstract
359. Nimura CA, Milani C, Tan ET, et al. Parsonage-Turner syndrome following monkeypox infection and vaccination. Skeletal Radiol. 2023 Feb 8 [Epub ahead of print].Full text Abstract
360. Warner NC, Shishido A, Fulco PP, et al. Immune reconstitution inflammatory syndrome due to monkeypox in two patients with AIDS. AIDS. 2023 Jun 1;37(7):1187-8. Abstract
361. Abdulkarim B, Ticknor IL, Torres AR, et al. Cutaneous findings of fulminant monkeypox in a patient with HIV/AIDS. JAAD Case Rep. 2023 Aug;38:32-4.Full text
362. Pinnetti C, Cimini E, Mazzotta V, et al. Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications. Lancet Infect Dis. 2023 Sep 28:S1473-3099(23)00482-6.Full text Abstract
363. Courdurié A, Buscot M, Gonfrier G, et al. MPox virus: an unusual aetiology of peritonitis. Sex Transm Infect. 2023 Mar 16 [Epub ahead of print].Full text Abstract
364. Ssemmondo E, Idris MA, Mawer D, et al. Subacute thyroiditis following mpox infection in a patient with human immunodeficiency virus. Endocrinol Diabetes Metab Case Rep. 2023 Aug 16;2023(3):23-0034.Full text Abstract
365. Centers for Disease Control and Prevention. Mpox: isolation and infection control at home. August 2022 [internet publication].Full text
366. Meister TL, Tao R, Brüggemann Y, et al. Efficient inactivation of monkeypox virus by World Health Organization-recommended hand rub formulations and alcohols. Emerg Infect Dis. 2022 Nov 17;29(1).Full text Abstract
367. Seang S, Burrel S, Todesco E, et al. Evidence of human-to-dog transmission of monkeypox virus. Lancet. 2022 Aug 27;400(10353):658-9.Full text Abstract
368. Sykes JE. A call for more evidence documenting human-to-dog transmission of monkeypox virus. Lancet. 2022 Sep 24;400(10357):993.Full text Abstract
369. Shepherd W, Beard PM, Brookes SM, et al. The risk of reverse zoonotic transmission to pet animals during the current global monkeypox outbreak, United Kingdom, June to mid-September 2022. Euro Surveill. 2022 Sep;27(39).Full text Abstract
370. World Health Organization. Second meeting of the International Health Regulations (2005) (IHR) Emergency Committee regarding the multi-country outbreak of monkeypox. July 2022 [internet publication].Full text
371. Knight C, Andreani J, Garrett N, et al. Absence of detectable monkeypox virus DNA in 11,000 English blood donations during the 2022 outbreak. Transfusion. 2023 Apr;63(4):690-5.Full text Abstract
372. Jacobs JW, Filkins L, Booth GS, et al. The potential impact of monkeypox infection and vaccination on blood donor deferrals and the blood supply. Br J Haematol. 2022 Nov;199(3):443-6.Full text Abstract
373. Association for the Advancement of Blood and Biotherapies. Regulatory update: TTD committee releases monkeypox virus outbreak summary. May 2022 [internet publication].Full text
374. Harvala H, Simmonds P. Evaluating the risk of transfusion and transplant-transmitted monkeypox infections. Transfus Med. 2022 Sep 22 [Epub ahead of print].Full text Abstract
375. US Food and Drug Administration. Information for blood establishments regarding the monkeypox virus and blood donation. August 2022 [internet publication].Full text
376. US Food and Drug Administration. Safety alert regarding use of fecal microbiota for transplantation and additional safety protections pertaining to monkeypox virus. August 2022 [internet publication].Full text
377. Ianiro G, Mullish BH, Iqbal TH, et al. Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel. Lancet Gastroenterol Hepatol. 2022 Nov;7(11):979-80.Full text Abstract
378. Pugliese P, Arvieux C, Huleux T, et al. Proposal of the French HIV Society on the CD4 threshold below which patients living with HIV who wish to be vaccinated against monkeypox should receive a 3-dose regimen. Infect Dis Now. 2022 Sep 14 [Epub ahead of print].Full text Abstract
379. Adalja A, Inglesby T. A novel international monkeypox outbreak. Ann Intern Med. 2022 Aug;175(8):1175-6.Full text Abstract
380. Jezek Z, Marennikova SS, Mutumbo M, et al. Human monkeypox: a study of 2,510 contacts of 214 patients. J Infect Dis. 1986 Oct;154(4):551-5. Abstract
381. Payne AB, Ray LC, Kugeler KJ, et al. Incidence of monkeypox among unvaccinated persons compared with persons receiving ≥1 JYNNEOS vaccine dose: 32 U.S. jurisdictions, July 31 - September 3, 2022. MMWR Morb Mortal Wkly Rep. 2022 Oct 7;71(40):1278-82.Full text Abstract
382. Sagy YW, Zucker R, Hammerman A, et al. Real-world effectiveness of a single dose of mpox vaccine in males. Nat Med. 2023 Jan 31 [Epub ahead of print].Full text Abstract
383. Bertran M, Andrews N, Davison C, et al. Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study. Lancet Infect Dis. 2023 Mar 13 [Epub ahead of print].Full text Abstract
384. Centers for Disease Control and Prevention. Estimated effectiveness of JYNNEOS vaccine in preventing mpox: a multijurisdictional case-control study - United States, August 19, 2022-March 31, 2023. May 2023 [internet publication].Full text
385. Centers for Disease Control and Prevention. Effectiveness of JYNNEOS vaccine against diagnosed mpox infection - New York, 2022. May 2023 [internet publication].Full text
386. Montero Morales L, Barbas Del Buey JF, Alonso García M, et al. Post-exposure vaccine effectiveness and contact management in the mpox outbreak, Madrid, Spain, May to August 2022. Euro Surveill. 2023 Jun;28(24):2200883.Full text Abstract
387. Moschetta N, Raccagni AR, Bianchi M, et al. Mpox neutralising antibodies at 6 months from mpox infection or MVA-BN vaccination: a comparative analysis. Lancet Infect Dis. 2023 Nov;23(11):e455-6.Full text
388. Hazra A, Rusie L, Hedberg T, et al. Human monkeypox virus infection in the immediate period after receiving modified vaccinia Ankara vaccine. JAMA. 2022 Sep 30 [Epub ahead of print].Full text Abstract
Use of this content is subject to our disclaimer